Some patients find that taking their injection in the evening rather than morning reduces daytime gastrointestinal symptoms
Ost, L., Wettrell, G., Bjrkhem, I., & Rane, A
Studies and safety reports have linked some of these products to dosing errors, severe side effects, hospitalizations, and other adverse outcomes
for others, the tradeoffs may outweigh the benefits
Product Information GHK Copper Peptide Powder is a compound formed by the complexation of copper ions and tripeptide-1
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy